Today: 21 May 2026
Dow, S&P 500, Nasdaq futures slide as silver rout spills over — what to know before Wall Street opens
2 February 2026
2 mins read

Dow, S&P 500, Nasdaq futures slide as silver rout spills over — what to know before Wall Street opens

New York, Feb 2, 2026, 05:59 EST — Premarket

  • S&P 500 futures dip roughly 1% in early action, pressured by a steep drop in precious metals that’s spurring caution among investors.
  • Gold and silver continue to swing sharply following CME Group’s hike in margin requirements, fueling more forced selling.
  • The coming week is loaded with mega-cap earnings, while the January U.S. jobs report on Feb. 6 stands out as a key upcoming test.

U.S. stock index futures slipped Monday, dragged down by ongoing declines in silver and gold that spilled over into wider markets before the New York open. Nasdaq Composite futures took a bigger hit compared to Dow Jones Industrial Average futures as traders prepared for more de-risking.

The timing couldn’t be more awkward. Investors kick off a week loaded with central bank meetings, a crucial U.S. jobs report, and another round of Big Tech earnings—right after last week’s surprise jolts came from commodities, not stocks.

Silver’s slump has hit a point where action is unavoidable. When positions get unwound, traders tend to offload anything they can — not just their preferred assets — to raise cash.

Wall Street closed last Friday lower. The S&P 500 dipped 0.4% to 6,939.03, the Dow dropped 0.4% to 48,892.47, and the Nasdaq slid 0.9% to 23,461.82.

In metals, attention is squarely on leverage and the market’s plumbing. CME pushed up margin requirements—the cash traders must post to maintain futures positions—and this will hit hard after Monday’s close. The selloff, which kicked off once Donald Trump tapped Kevin Warsh to replace Jerome Powell, looks set to deepen. “It is definitely creating a sort of feedback loop,” said Zain Vawda, an analyst at MarketPulse by OANDA. Reuters

The commodity selloff has been widespread. Oil dropped close to 5%, copper also lost ground, and IG analyst Tony Sycamore described the “scale of the unwind” in gold as unprecedented since 2008, highlighting leveraged positions being “flushed” and stop-loss selling. Reuters

The Fed backdrop isn’t exactly lending support. Rate futures are still betting on two quarter-point cuts in 2026 from the current 3.50%-3.75% range, Reuters noted. But investors are also trying to gauge what Warsh’s arrival means for the Fed’s easing appetite and its plans for the balance sheet. Heather Long, chief economist at Navy Federal Credit Union, described Warsh as “a pragmatist” who wouldn’t want to risk market trust with “cuts that aren’t warranted.” Reuters

Energy prices took another hit. Brent tumbled $3.63 to $65.69 a barrel, while U.S. crude slid $3.60 to $61.61. The drop followed Trump’s comment that Iran was “seriously talking” with Washington, which eased near-term supply worries and trimmed some of the risk premium built up since January. Reuters

Earnings are set to carry the weight this week. Investors will focus on reports from Alphabet, Amazon, Advanced Micro Devices, Walt Disney, Palantir, and Eli Lilly. The key question: is spending—particularly on AI—driving revenue growth, or just swelling capex budgets?

The immediate danger seems blunt: forced unwindings may continue well beyond the initial trigger. If margin calls and volatility stick around, index futures could remain stuck on the downside, while liquidity dries up quickly.

Friday’s U.S. Employment Situation report for January, set for release at 8:30 a.m. ET, stands as the next major catalyst. If the labor market data comes in unexpectedly, it could shift rate-cut expectations once more.

Stock Market Today

  • Analysts Boost Broadcom Price Targets Despite Stock Dip
    May 20, 2026, 11:22 PM EDT. Broadcom (AVGO) shares fell 6.5% to $411.07 on May 19, retreating from a record high of $439.79 on May 14. Despite this drop, several major analysts raised their price targets. Wells Fargo lifted its target to $545 from $430, TD Cowen to $500 from $405, and UBS to $490 from $475, all maintaining buy ratings. Evercore ISI's Mark Lipacis, a top-ranked analyst, raised his target to $582, citing growing demand for Broadcom's custom AI chips amid shifts in AI workloads. Risks remain from semiconductor market volatility and geopolitical tensions impacting chip deals. Broadcom's strategic moves, including its VMware acquisition and partnerships with Google and Meta for AI-focused chips, position it well in enterprise infrastructure and AI growth.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs
Previous Story

Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs

Nvidia stock slips before the bell as OpenAI funding talk shifts and earnings loom
Next Story

Nvidia stock slips before the bell as OpenAI funding talk shifts and earnings loom

Go toTop